A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation
D D Rees, R M Palmer, H F Hodson, S Moncada, D D Rees, R M Palmer, H F Hodson, S Moncada
Abstract
1. The role of L-arginine in the basal and stimulated generation of nitric oxide (NO) for endothelium-dependent relaxation was studied by use of NG-monomethyl L-arginine (L-NMMA), a specific inhibitor of this pathway. 2. L-Arginine (10-100 microM), but not D-arginine (100 microM), induced small but significant endothelium-dependent relaxations of rings of rabbit aorta. In contrast, L-NMMA (1-300 microM) produced small, endothelium-dependent contractions, while its enantiomer NG-monomethyl-D-arginine (D-NMMA; 100 microM) had no effect. 3. L-NMMA (1-300 microM) inhibited endothelium-dependent relaxations induced by acetylcholine (ACh), the calcium ionophore A23187, substance P or L-arginine without affecting the endothelium-independent relaxations induced by glyceryl trinitrate or sodium nitroprusside. 4. The inhibition of endothelium-dependent relaxation by L-NMMA (30 microM) was reversed by L-arginine (3-300 microM) but not by D-arginine (300 microM) or a number of close analogues (100 microM). 5. The release of NO induced by ACh from perfused segments of rabbit aorta was also inhibited by L-NMMA (3-300 microM), but not by D-NMMA (100 microM) and this effect of L-NMMA was reversed by L-arginine (3-300 microM). 6. These results support the proposal that L-arginine is the physiological precursor for the basal and stimulated generation of NO for endothelium-dependent relaxation.
References
- Acta Biochim Biophys Acad Sci Hung. 1977;12(3):191-6
- Br J Pharmacol. 1988 Nov;95(3):830-4
- J Pharmacol Exp Ther. 1985 Mar;232(3):708-16
- Nature. 1986 Apr 3-9;320(6061):454-6
- Br J Pharmacol. 1986 Apr;87(4):685-94
- J Immunol. 1987 Jan 15;138(2):550-65
- Science. 1987 Jan 23;235(4787):473-6
- Biochem Biophys Res Commun. 1987 Apr 29;144(2):829-35
- Nature. 1987 Jun 11-17;327(6122):524-6
- Proc Natl Acad Sci U S A. 1987 Sep;84(18):6369-73
- Biochem Biophys Res Commun. 1987 Nov 13;148(3):1482-9
- J Leukoc Biol. 1988 Feb;43(2):187-92
- Br J Pharmacol. 1987 Nov;92(3):639-46
- J Clin Invest. 1988 Apr;81(4):1129-36
- J Pharmacol Exp Ther. 1988 Apr;245(1):102-11
- Br J Pharmacol. 1988 Mar;93(3):515-24
- Nature. 1988 Jun 16;333(6174):664-6
- Eur J Pharmacol. 1988 Mar 29;148(2):293-5
- Biochem Biophys Res Commun. 1988 Jun 30;153(3):1251-6
- Biochem Pharmacol. 1988 Jul 1;37(13):2495-501
- Eur J Pharmacol. 1988 May 20;150(1-2):149-54
- Nature. 1980 Nov 27;288(5789):373-6
Source: PubMed